PMPaula Camila Alves de Assis Pereira Matos

Paula Camila Alves de Assis Pereira Matos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paula Camila Alves de Assis Pereira Matos has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Opsoclonus‐Myoclonus‐Ataxia Revealing Underlying Neuromyelitis Optica Spectrum Disorder

    by Ana Silvia Sobreira Lima Verde, Flávia de Paiva Santos Rolim, Amanda Vale Catunda, José Orlando Ferreira Tomé Filho, Milena Sales Pitombeira, Fernanda Martins Maia Carvalho, Paula Camila Alves de Assis Pereira Matos

  • Cognitive and psychiatric profile in a Brazilian case of SNCA duplication

    by Flávia de Paiva Santos Rolim, Sylvio Ricard Gonçalves de Souza Lima, Ana Silvia Sobreira Lima Verde, Paulo Sérgio Alves Lisboa, Ingrid César Fernandes, Paula Camila A.A.P. Matos, Verônica Tavares Aragão, André Borges Ferreira Gomes, Norberto Anizio Ferreira Frota, Sarah Teixeira Camargos, et al.

  • Open Access

    Oropouche Fever Associated with Combined Central and Peripheral Demyelination (CCPD): A Case Report from Ceará, Brazil, 2024

    by Carlos Garcia Filho, Antonio Silva Lima Neto, Ana Maria Cabral Maia, Fernanda Martins Maia Carvalho, Matheus Andrighetti Rossi, Milena Sales Pitombeira, Paula Camila Alves de Assis Pereira Mato, Tania Mara Silva Coelho, Lauro Vieira Perdigão Neto, Lívia Mendes de Almeida, et al.

    Background: Oropouche fever, caused by the Oropouche orthobunyavirus (OROV), is an arboviral illness transmitted by midges and mosquitoes. Although commonly regarded as a mild illness, severe neurological manifestations are increasingly being reported. Case Summary: We report a 48-year-old female patient without comorbidities, from Capistrano, Ceará, Brazil, who developed Combined Central and Peripheral Demyelination (CCPD) following confirmed OROV infection. Her clinical presentation included ascending flaccid tetraparesis, bilateral facial paresis, and progressive visual loss. Neurological investigation confirmed demyelinating polyneuropathy and retrobulbar optic neuritis. Despite initial corticosteroid therapy, gradual and partial clinical improvement was observed after plasmapheresis; however, visual and motor deficits persisted even after 90 days. Conclusion: A reported case of combined central and peripheral demyelination (CCPD) associated with OROV represents an unprecedented complication, emphasizing the potential for severe outcomes linked to OROV infection. This highlights the need for increased clinical awareness and greater attention to the epidemiology of this disease. OROV infection has demonstrated the capacity to cause severe neuroinvasive complications, underscoring its critical and emerging epidemiological significance amidst the ongoing epidemic in the Americas. Driven by a novel reassortant lineage of OROV, this outbreak has been associated with previously unreported severe manifestations, including adult and fetal deaths. Enhanced surveillance systems and targeted training for the early recognition of neurological complications are essential to mitigate long-term impacts and guide public health strategies to address the growing burden of this arboviral infection.